In the Lab By Sharon Begley Our body systems age at different rates, study finds, pointing to personalized care to extend healthy life
First Opinion By Kimi Vesel My compulsive hair pulling and skin picking could be solved with a precision medicine approach
First Opinion By Lee D. Cooper Genetic testing plus IVF can sidestep genetic disease and reduce the need for high-priced therapies
Business By Rebecca Robbins With human drugs, a Silicon Valley startup hopes to deliver precision medicine to dogs
Health By Bob Tedeschi For cancer patients, newest treatments force the ultimate decision, with no room for error
Health By Elizabeth Cooney Recapping ASCO 2020, talking cancer therapy combinations, and looking to the future
Biotech By Elizabeth Cooney Startup Spotlight: Aiming to speed precision cancer therapies to children
First Opinion By Richard Cooper and Nigel Paneth Precision medicine: course correction urgently needed
First Opinion By David A. Pearce We need better regulation of stem cell therapies, especially rogue clinics
In the Lab By Karen Weintraub Growing tumors in a dish, scientists try to personalize pancreatic cancer treatment
Health Tech By Casey Ross How an AI expert took on his toughest project ever: writing code to save his son’s life
First Opinion By Edward Abrahams Personalized treatments may be threatened by drug cost-containment proposals
In the Lab By Sharon Begley Buffalo gave us spicy wings and the ‘book of life.’ Here’s why that’s undermining personalized medicine
Health By Rebecca Robbins, Adam Feuerstein, and Damian Garde He went hunting for gold-standard research on artificial intelligence in medicine — and didn’t find much
First Opinion By Michael J. Joyner and Nigel Paneth Precision medicine’s rosy predictions haven’t come true. We need fewer promises and more debate
First Opinion By Harris A. Gelbard Multi-target drugs should be in the pharma pipeline along with precision drugs
Biotech By Jonathan Saltzman — Boston Globe For one cancer patient, biotech’s genetic test turns out to be a ‘lifesaver’
Health By Liz Szabo — Kaiser Health News Pricey precision medicine often financially toxic for cancer patients
First Opinion By Richard G. Hamermesh and Kathy E. Giusti Precision medicine needs a business mindset in order to flourish
First Opinion By Joel C. White Administrative delays threaten the promise of the 21st Century Cures Act
First Opinion By Franklin W. Maddux Kidney disease is a killer. More precise classification can help tame it
First Opinion By Akbar K. Waljee, Sameer D. Saini, and Brahmajee Nallamothu Doctors could prescribe drugs more accurately — if they could get the data
In the Lab By Megan Thielking Can precision medicine do for depression what it’s done for cancer? It won’t be easy
In the Lab By Megha Satyanarayana Scientists created neurons from people who are extremely overweight. Is this the future of personalized obesity treatment?